Progesterone Action in Endometrial Cancer, Endometriosis, Uterine Fibroids, and Breast Cancer
Open accessThe DOI matches its Crossref record; 335 of the 343 references it cites were found in a registry or an index.
Abstract
Progesterone receptor (PR) mediates the actions of the ovarian steroid progesterone, which together with estradiol regulates gonadotropin secretion, prepares the endometrium for implantation, maintains pregnancy, and differentiates breast tissue. Separation of estrogen and progesterone actions in hormone-responsive tissues remains a challenge. Pathologies of the uterus and breast, including endometrial cancer, endometriosis, uterine fibroids, and breast cancer, are highly associated with estrogen, considered to be the mitogenic factor. Emerging evidence supports distinct roles of progesterone and its influence on the pathogenesis of these diseases. Progesterone antagonizes estrogen-driven growth in the endometrium, and insufficient progesterone action strikingly increases the risk of endometrial cancer. In endometriosis, eutopic and ectopic tissues do not respond sufficiently to progesterone and are considered to be progesterone-resistant, which contributes to proliferation and survival. In uterine fibroids, progesterone promotes growth by increasing proliferation, cellular hypertrophy, and deposition of extracellular matrix. In normal mammary tissue and breast cancer, progesterone is pro-proliferative and carcinogenic. A key difference between these tissues that could explain the diverse effects of progesterone is the paracrine interactions of PR-expressing stroma and epithelium. Normal endometrium is a mucosa containing large quantities of distinct stromal cells with abundant PR, which influences epithelial cell proliferation and differentiation and protects against carcinogenic transformation. In contrast, the primary target cells of progesterone in the breast and fibroids are the mammary epithelial cells and the leiomyoma cells, which lack specifically organized stromal components with significant PR expression. This review provides a unifying perspective for the diverse effects of progesterone across human tissues and diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“endometriotic stromal cells are poorly differentiated with deficient PRs and fail to send physiological paracrine signals to adjacent epithelial cells, explaining the absence of response in more than 30% of women treated with progestins [58,84].”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [84]
In the citing paper
“PR deficiency is evident in endometriotic lesions, leading to progesterone resistance and defective progesterone action, with obvious consequences on the survival and development of endometriotic tissues [15,22,84].”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [84]
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
Siegel, R., Ward, E., Brawley, O., & Jemal, A. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20121 · Cited by 4,070
Gene regulation by steroid hormones
Beato, M. (1989) · Cell · doi:10.1016/0092-8674(89)90237-7 · Cited by 3,383
Giudice, L. C., & Kao, L. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17403-5 · Cited by 3,166
Breast cancer and hormone-replacement therapy in the Million Women Study
(2003) · The Lancet · doi:10.1016/s0140-6736(03)14065-2 · Cited by 2,993
MOLECULAR MECHANISMS OF ACTION OF STEROID/THYROID RECEPTOR SUPERFAMILY MEMBERS
Tsai, M.-J., & O'Malley, B. W. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.002315 · Cited by 2,932
Two pathogenetic types of endometrial carcinoma
Bokhman, J. V. (1983) · Gynecologic Oncology · doi:10.1016/0090-8258(83)90111-7 · Cited by 2,494
High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence
Day Baird, D., Dunson, D. B., Hill, M. C., Cousins, D., & Schectman, J. M. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.99 · Cited by 2,435
Research works printed but not linked: 1
- Kim, 1997, Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature, Cancer, 79, 320, 10.1002/(sici)1097-0142(19970115)79:2<320::aid-cncr15>3.0.co;2-2 · DOI · Paper page
Cited by
Manson, J. E., Chlebowski, R. T., Stefanick, M. L., Aragaki, A. K., Rossouw, J. E., Prentice, R. L., Anderson, G., Howard, B. V., Thomson, C. A., LaCroix, A. Z., et al. (2013) · JAMA · doi:10.1001/jama.2013.278040 · Cited by 1,650
Bulun, S. E., Yilmaz, B. D., Sison, C., Miyazaki, K., Bernardi, L., Liu, S., Kohlmeier, A., Yin, P., Milad, M., & Wei, J. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00242 · Cited by 844
Self-citationManson, J. E., Aragaki, A. K., Rossouw, J. E., Anderson, G. L., Prentice, R. L., LaCroix, A. Z., Chlebowski, R. T., Howard, B. V., Thomson, C. A., Margolis, K. L., et al. (2017) · JAMA · doi:10.1001/jama.2017.11217 · Cited by 638
Theories on the pathogenesis of endometriosis
Sourial, S., Tempest, N., & Hapangama, D. K. (2014) · International Journal of Reproductive Medicine · doi:10.1155/2014/179515 · Cited by 418
“Many authors believe that endometriosis is associated with resistance of the endometrium to progesterone which plays a pivotal role in the pathogenesis [33, 34].”
BackgroundHan, S. J., Jung, S. Y., Wu, S.-P., Hawkins, S. M., Park, M. J., Kyo, S., Qin, J., Lydon, J. P., Tsai, S. Y., Tsai, M.-J., et al. (2015) · Cell · doi:10.1016/j.cell.2015.10.034 · Cited by 380
Role of nuclear progesterone receptor isoforms in uterine pathophysiology
Patel, B., Elguero, S., Thakore, S., Dahoud, W., Bedaiwy, M., & Mesiano, S. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmu056 · Cited by 353
The Main Theories on the Pathogenesis of Endometriosis
Lamceva, J., Uljanovs, R., & Strumfa, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054254 · Cited by 324
Progesterone and Breast Cancer
Trabert, B., Sherman, M. E., Kannan, N., & Stanczyk, F. Z. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnz001 · Cited by 271
Treatment of endometriosis: a review with comparison of 8 guidelines
Kalaitzopoulos, D. R., Samartzis, N., Kolovos, G. N., Mareti, E., Samartzis, E. P., Eberhard, M., Dinas, K., & Daniilidis, A. (2021) · BMC Women's Health · doi:10.1186/s12905-021-01545-5 · Cited by 209
Endometriosis and nuclear receptors
Yilmaz, B. D., & Bulun, S. E. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz005 · Cited by 243
Self-citationAromatase expression and regulation in breast and endometrial cancer
Zhao, H., Zhou, L., Shangguan, A. J., & Bulun, S. E. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0310 · Cited by 216
Self-citationRole of the steroidogenic acute regulatory protein in health and disease
Manna, P. R., Stetson, C. L., Slominski, A. T., & Pruitt, K. (2016) · Endocrine · doi:10.1007/s12020-015-0715-6 · Cited by 206
Progesterone action in breast, uterine, and ovarian cancers
Diep, C. H., Daniel, A. R., Mauro, L. J., Knutson, T. P., & Lange, C. A. (2015) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0252 · Cited by 190
Progesterone Actions and Resistance in Gynecological Disorders
MacLean, J. A., & Hayashi, K. (2022) · Cells · doi:10.3390/cells11040647 · Cited by 176
Commandeur, A. E., Styer, A. K., & Teixeira, J. M. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv030 · Cited by 186
Recent Advances in Uterine Fibroid Etiology
McWilliams, M., & Chennathukuzhi, V. (2017) · Seminars in Reproductive Medicine · doi:10.1055/s-0037-1599090 · Cited by 181
Donnez, J., & Dolmans, M.-M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10051085 · Cited by 182
Samartzis, E., Noske, A., Dedes, K., Fink, D., & Imesch, P. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140918824 · Cited by 171
Reis, F. M., Coutinho, L. M., Vannuccini, S., Batteux, F., Chapron, C., & Petraglia, F. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmaa009 · Cited by 166
Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy
Borahay, M. A., Al-Hendy, A., Kilic, G. S., & Boehning, D. (2015) · Molecular Medicine · doi:10.2119/molmed.2014.00053 · Cited by 158
Endometrial progesterone resistance and PCOS
Li, X., Feng, Y., Jin-fang, L., Billig, H., & Shao, R. (2014) · Journal of Biomedical Science · doi:10.1186/1423-0127-21-2 · Cited by 176
Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications
Moravek, M. B., Yin, P., Ono, M., Coon, J. S., Dyson, M. T., Navarro, A., Marsh, E. E., Chakravarti, D., Kim, J. J., Wei, J., et al. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu048 · Cited by 163
Self-citationSelective Progesterone Receptor Modulators—Mechanisms and Therapeutic Utility
Islam, M. S., Afrin, S., Jones, S. I., & Segars, J. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa012 · Cited by 143
Fraser, S. P., Ozerlat‐Gunduz, I., Brackenbury, W. J., Fitzgerald, E. M., Campbell, T. M., Coombes, R. C., & Djamgoz, M. B. A. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0105 · Cited by 143
Endometriosis and risks for ovarian, endometrial and breast cancers: A nationwide cohort study
Mogensen, J. B., Kjær, S. K., Mellemkjær, L., & Jensen, A. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.07.095 · Cited by 141
Review of the literature on combined oral contraceptives and cancer
Kamani, M. O., Akgör, U., & Gültekin, M. (2022) · ecancermedicalscience · doi:10.3332/ecancer.2022.1416 · Cited by 133
Chlebowski, R. T., Anderson, G. L., Sarto, G. E., Haque, R., Runowicz, C. D., Aragaki, A. K., Thomson, C. A., Howard, B. V., Wactawski‐Wende, J., Chen, C., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv350 · Cited by 109
Progesterone receptor signaling in the initiation of pregnancy and preservation of a healthy uterus
Wetendorf, M., & DeMayo, F. J. (2014) · The International Journal of Developmental Biology · doi:10.1387/ijdb.140069mw · Cited by 116
Immunotherapy in endometrial cancer: rationale, practice and perspectives
Cao, W., Ma, X., Fischer, J. V., Sun, C., Kong, B., & Zhang, Q. H. (2021) · Biomarker Research · doi:10.1186/s40364-021-00301-z · Cited by 112
The modern management of uterine fibroids-related abnormal uterine bleeding
Vannuccini, S., Petraglia, F., Carmona, F., Calaf, J., & Chapron, C. (2024) · Fertility and Sterility · doi:10.1016/j.fertnstert.2024.04.041 · Cited by 106
Epithelial Mutations in Endometriosis: Link to Ovarian Cancer
Bulun, S. E., Wan, Y., & Matei, D. E. (2019) · Endocrinology · doi:10.1210/en.2018-00794 · Cited by 112
Self-citationBaker, M. E., Nelson, D. R., & Studer, R. A. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.10.020 · Cited by 106
Epidemiology of Endometrial Carcinoma: Etiologic Importance of Hormonal and Metabolic Influences
Felix, A. S., Yang, H., Bell, D. W., & Sherman, M. E. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-43139-0_1 · Cited by 107
Endocrine disrupting chemicals and reproductive disorders in women, men, and animal models
Laws, M. J., Neff, A. M., Brehm, E., Warner, G. R., & Flaws, J. A. (2021) · Advances in pharmacology · doi:10.1016/bs.apha.2021.03.008 · Cited by 103
Houshdaran, S., Oke, A., Fung, J. C., Vo, K. C., NEZHAT, C. R., & Giudice, L. C. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008601 · Cited by 93
Role of nuclear receptors in blastocyst implantation
Vasquez, Y. M., & DeMayo, F. J. (2013) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2013.08.004 · Cited by 91
Medical treatment for adenomyosis and/or adenomyoma
Tsui, K., Lee, W.-L., Chen, C.-Y., Sheu, B., Yen, M., Chang, T., & Wang, P. (2014) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2014.04.024 · Cited by 85
Endocrinology of uterine fibroids: steroid hormones, stem cells, and genetic contribution
Moravek, M. B., & Bulun, S. E. (2015) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000185 · Cited by 83
Self-citationHRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT
L’Hermite, M. (2013) · Climacteric · doi:10.3109/13697137.2013.808563 · Cited by 83
Does dienogest influence the inflammatory response of endometriotic cells? A systematic review
Grandi, G., Mueller, M. D., Bersinger, N. A., Cagnacci, A., Volpe, A., & McKinnon, B. D. (2015) · Inflammation Research · doi:10.1007/s00011-015-0909-7 · Cited by 94
Chi, A., Wang, T., Adams, N. R., Wu, S., Young, S. L., Spencer, T. E., & DeMayo, F. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz117 · Cited by 81
Fibroid growth and medical options for treatment
Chabbert‐Buffet, N., Esber, N., & Bouchard, P. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.07.1238 · Cited by 78
The role of mitogen‐activated protein kinase signaling pathway in endometriosis
Bora, G., & Yaba, A. (2021) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14710 · Cited by 79
Huhtinen, K., Saloniemi-Heinonen, T., Keski-Rahkonen, P., Desai, R., Laajala, D., Ståhle, M., Häkkinen, M. R., Awosanya, M., Suvitie, P., Kujari, H., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1913 · Cited by 75
Ali, M. K., Ciebiera, M., Vafaei, S., Alkhrait, S., Chen, H.-Y., Chiang, Y., Huang, K., Feduniw, S., Hsia, S., & Al-Hendy, A. A. (2023) · Cells · doi:10.3390/cells12081117 · Cited by 76
Ye, J., Peng, H., Huang, X., & Qi, X. (2022) · BMC Women s Health · doi:10.1186/s12905-022-02028-x · Cited by 74
Miyazaki, K., Dyson, M. T., Coon, J. S., Furukawa, Y., Yilmaz, B. D., Maruyama, T., & Bulun, S. E. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.10.002 · Cited by 74
Self-citationPoole, E. M., Lin, W. T., Kvaskoff, M., Vivo, I. D., Terry, K. L., & Missmer, S. A. (2017) · Cancer Causes & Control · doi:10.1007/s10552-017-0856-4 · Cited by 78
Zhu, Y., Xu, Z., Gao, J., Ji, W., & Zhang, J. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112210 · Cited by 72
The hormonal composition of follicular fluid and its implications for ovarian cancer pathogenesis
Emori, M. M., & Drapkin, R. (2014) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-12-60 · Cited by 70
Uterine fibroids — Causes, impact, treatment, and lens to the African perspective
Sefah, N., Ndebele, S., Prince, L., Korasare, E., Agbleke, M., Nkansah, A., Thompson, H., Al-Hendy, A. A., & Agbleke, A. A. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1045783 · Cited by 68
Shao, R., Li, X., Feng, Y., Lin, J.-F., & Billig, H. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-33-41 · Cited by 70
Endometriosis, Leiomyoma and Adenomyosis: the Risk of Gynecologic Malignancy
Verit, F. F., & Yücel, O. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.10.5589 · Cited by 75
Chiu, H.-C., Li, C., Yiang, G., Tsai, A. P., & Wu, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8040439 · Cited by 65
Clark, N. C., Friel, A. M., Pru, C. A., Zhang, L., Shioda, T., Rueda, B. R., Peluso, J. J., & Pru, J. K. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2016.1139240 · Cited by 63
Zheng, Z., Zhang, G.-L., Jiang, R.-F., Hong, Y., Zhang, Q., He, J., Liu, X., Yang, Z., Yang, L., Jiang, X. Y., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2214684120 · Cited by 62
Braganza, M. Z., de González, A. B., Schonfeld, S. J., Wentzensen, N., Brenner, A. V., & Kitahara, C. M. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0367 · Cited by 62
Iizuka, T., Yin, P., Zuberi, A., Kujawa, S. A., Coon, J. S., Björvang, R. D., Damdimopoulou, P., Pacyga, D. C., Strakovsky, R. S., Flaws, J. A., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2208886119 · Cited by 61
Self-citationLi, X., Guo, Y.-R., Lin, J.-F., Feng, Y., Billig, H., & Shao, R. (2014) · Journal of Cancer · doi:10.7150/jca.8009 · Cited by 60
Progesterone activates GPR126 to promote breast cancer development via the Gi pathway
An, W., Lin, H., Ma, L., Zhang, C., Zheng, Y., Cheng, Q., Ma, C., Wu, X. Y., Zhang, Z., Zhong, Y.-N., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2117004119 · Cited by 58
Donnez, J., & Dolmans, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111342 · Cited by 61
Manson, J. E., Aragaki, A. K., Rossouw, J. E., Anderson, G. L., Prentice, R. L., LaCroix, A. Z., Chlebowski, R. T., Howard, B. V., Thomson, C. A., Margolis, K. L., et al. (2018) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000527868.87744.14 · Cited by 55
Liu, S., Yin, P., Kujawa, S. A., Coon, J. S., Okeigwe, I., & Bulun, S. E. (2018) · Oncogene · doi:10.1038/s41388-018-0612-6 · Cited by 55
Self-citationNaqvi, H., Sakr, S., Presti, T., Krikun, G., Komm, B., & Taylor, H. S. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.113.114165 · Cited by 54
Tsigkou, A., dos Reis, F. M., Lee, M. H., Jiang, B., Tosti, C., Centini, G., Shen, F., Chen, Y., & Petraglia, F. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.04.024 · Cited by 53
The Evolving Role of Natural Compounds in the Medical Treatment of Uterine Fibroids
Ciebiera, M., Ali, M. K., Prince, L., Jackson-Bey, T., Atabiekov, I., Zgliczyński, S., & Al-Hendy, A. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051479 · Cited by 56
Epigenetic Factors in Eutopic Endometrium in Women with Endometriosis and Infertility
Adamczyk, M., Wender-Ożegowska, E., & Kędzia, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073804 · Cited by 53
Zhang, Y., Lu, Y., Ma, H., Xu, Q., & Wu, X. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.726876 · Cited by 52
Kendziorski, J. A., & Belcher, S. M. (2015) · Reproductive Toxicology · doi:10.1016/j.reprotox.2015.08.001 · Cited by 52
Clark, N., Pru, C. A., Yee, S., Lydon, J. P., Jj, P., & Pru, J. K. (2016) · Endocrinology · doi:10.1210/en.2016-1701 · Cited by 53
Endometrium and steroids, a pathologic overview
Plaza-Parrochia, F., Romero, C., Valladares, L., & Vega, M. (2017) · Steroids · doi:10.1016/j.steroids.2017.08.007 · Cited by 59
Targeting progesterone signaling prevents metastatic ovarian cancer
Kim, O., Park, E. Y., Kwon, S. Y., Shin, S., Emerson, R. E., Shin, Y.-H., DeMayo, F. J., Lydon, J. P., Coffey, D. M., Hawkins, S. M., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2013595117 · Cited by 56
Self-citationEndometrial Atypical Hyperplasia and Risk of Endometrial Cancer
Chou, A.-J., Bing, R.-S., & Ding, D. (2024) · Diagnostics · doi:10.3390/diagnostics14222471 · Cited by 49
Li, X., Pishdari, B., Cui, P., Hu, M., Yang, H.-P., Guo, Y.-R., Jiang, H., Feng, Y., Billig, H., & Shao, R. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.13109 · Cited by 48
Gandini, S., Lazzeroni, M., Peccatori, F. A., Bendinelli, B., Saieva, C., Palli, D., Masala, G., & Caini, S. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.12.009 · Cited by 49
Advances of aptamer-based small-molecules sensors in body fluids detection
Chen, L., Yang, G., & Qu, F. (2023) · Talanta · doi:10.1016/j.talanta.2023.125348 · Cited by 46
Influence of AKT on Progesterone Action in Endometrial Diseases
Lee, I. I., & Kim, J. J. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.114.119255 · Cited by 49
Self-citationMobile phone based ELISA (MELISA)
Zhdanov, A., Keefe, J., Franco-Waite, L., Konnaiyan, K. R., & Pyayt, A. L. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.12.033 · Cited by 47
Malik, M., Britten, J., Borahay, M. A., Segars, J. H., & Catherino, W. H. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.07.024 · Cited by 46
Hormonal therapy in uterine sarcomas
Zang, Y., Dong, M., Zhang, K., Gao, C., Guo, F., Wang, Y., & Xue, F. (2019) · Cancer Medicine · doi:10.1002/cam4.2044 · Cited by 48
Jackson-Bey, T., Colina, J. A., Isenberg, B. C., Coppeta, J. R., Urbanek, M., Kim, J. J., Woodruff, T. K., Burdette, J. E., & Russo, A. (2020) · Human Reproduction · doi:10.1093/humrep/deaa157 · Cited by 51
Self-citationGoldrat, O., Gervy, C., Englert, Y., Delbaere, A., & Demeestere, I. (2015) · Human Reproduction · doi:10.1093/humrep/dev155 · Cited by 45
Immunomodulatory effects of progesterone and selective ligands of membrane progesterone receptors
Polikarpova, A. V., Levina, I. S., Сигай, Н. В., Zavarzin, I. V., Morozov, I. A., Рубцов, П. М., Guseva, A. A., Smirnova, О. V., & Shchelkunova, T. A. (2019) · Steroids · doi:10.1016/j.steroids.2019.02.009 · Cited by 45
Exposure to endocrine disruptor alkylphenols and the occurrence of endometrial cancer
Wen, H., Chang, T.-C., Ding, W.-H., Tsai, S.-F., Hsiung, C. A., & Wang, S. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.115475 · Cited by 45
Mick, I., Freger, S., van Keizerswaard, J., Gholiof, M., & Leonardi, M. (2024) · Therapeutic Advances in Reproductive Health · doi:10.1177/26334941241277759 · Cited by 52
Prather, G. R., MacLean, J. A., Shi, M., Boadu, D., Paquet, M., & Hayashi, K. (2016) · Biology of Reproduction · doi:10.1095/biolreprod.116.140236 · Cited by 47
Medina-Laver, Y., Rodríguez-Varela, C., Salsano, S., Labarta, E., & Domínguez, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011278 · Cited by 47
Sinreih, M., Knific, T., Thomas, P., Grazio, S. F., & Rižner, T. L. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.01.011 · Cited by 43
The Krüppel-like factors in female reproductive system pathologies
Simmen, R. C. M., Heard, M. E., Simmen, A. M., Montales, M. T. E., Marji, M., Scanlon, S. A., & Pabona, J. M. P. (2015) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0310 · Cited by 43
Dysregulation of Aromatase in Breast, Endometrial, and Ovarian Cancers
Manna, P. R., Molehin, D., & Ahmed, A. U. (2016) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.10.002 · Cited by 45
Neff, A. M., Blanco, S. C., Flaws, J. A., Bagchi, I. C., & Bagchi, M. K. (2019) · Endocrinology · doi:10.1210/en.2018-00872 · Cited by 42
Uterine Fibroids and Progestogen Treatment: Lack of Evidence of Its Efficacy: A Review
Donnez, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123948 · Cited by 46
Hilton, H. N., Graham, J. D., & Clarke, C. L. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1152 · Cited by 48
Current Knowledge on Endometriosis Etiology: A Systematic Review of Literature
Михалева, Л. М., Radzinsky, V. E., Orazov, M. R., Николаевна, Х. Т., Sorokina, A. V., Александрович, М. С., Владимировна, В. С., Shustova, V. B., & Sinelnikov, M. Y. (2021) · International Journal of Women s Health · doi:10.2147/ijwh.s306135 · Cited by 46
Sinreih, M., Anko, M., Zukunft, S., Adamski, J., & Rižner, T. L. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.11.012 · Cited by 41
Generation of Multicellular Human Primary Endometrial Organoids
Murphy, A. R., Wiwatpanit, T., Lu, Z., Davaadelger, B., & Kim, J. J. (2019) · Journal of Visualized Experiments · doi:10.3791/60384 · Cited by 40
Self-citationClinical Use of Progestins and Their Mechanisms of Action: Present and Future (Review)
Федотчева, Т. А. (2021) · Современные технологии в медицине · doi:10.17691/stm2021.13.1.11 · Cited by 40
Zeng, L., Yang, K., Liu, H., & Zhang, G. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5170 · Cited by 40
Metformin for endometrial hyperplasia
Clement, N. S., Oliver, T. R. W., Shiwani, H., Sanner, J. R., Mulvaney, C. A., & Atiomo, W. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012214.pub2 · Cited by 39
Evaluation of BCL6 and SIRT1 as Non-Invasive Diagnostic Markers of Endometriosis
Sansone, A. M., Hisrich, B. V., Young, R. B., Abel, W. F., Bowens, Z., Blair, B. B., Funkhouser, A., Schammel, D. P., Green, L. J., Lessey, B. A., et al. (2021) · Current Issues in Molecular Biology · doi:10.3390/cimb43030096 · Cited by 43
Metadata
- Authors
- Kim, J. J., Kurita, T., & Bulun, S. E.
- Affiliations
- Northwestern University (US)
- Corresponding author
- Bulun, Serdar E.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2013-01-09
- Volume
- 34
- Issue
- 1
- Pages
- 130-162
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC3565104
- OpenAlex
- W2023298070
- Cited by
- 520
- References
- 343
- Citations by year
- 2026: 29 · 2025: 38 · 2024: 49 · 2023: 41 · 2022: 46 · 2021: 44 · 2020: 38 · 2019: 40 · 2018: 28 · 2017: 34 · 2016: 38 · 2015: 35 · 2014: 45 · 2013: 15
- FWCI
- 5.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrine Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01CA155513, R21CA127674, R01CA154358)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD044715, R37-HD36891, P01HD057877, R01HD064402)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Keywords
- progesterone, progesterone receptor, endometrial cancer, endometriosis, uterine fibroids, breast cancer, estrogen, progesterone resistance, paracrine signaling, stromal-epithelial interactions, mammary epithelial cells, leiomyoma cells, extracellular matrix deposition, carcinogenesis, uterine pathology
- MeSH terms
- Animals, Breast Neoplasms, Cell Differentiation, Endometriosis, Estrogens, Female, Humans, Leiomyoma, Pregnancy, Progesterone, Receptors, Progesterone, Endometrial Neoplasms, Stromal Cells, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.